Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Historical time for N.O. , 93 reads but not a peep

<< Previous

Bullboard Posts

Next >>

Comment by PTBaileyon Feb 10, 2022 12:33am

131 Views

Post# 34415302

RE:Historical time for N.O. , 93 reads but not a peep

"Historical time for N.O. , 93 reads but not a peep"

Would make you think people are not interested in what you have say wouldn't it.

Especially when you post something "historic" and then have ask for people to respond. Kinda like asking people to applaud when you think you have said something profound. LOL

And what's this attemp to limit the peope who respond on ths form, don't you understand the concept and benefit of tapping into collecitve IQ?

"PT wll you shut up man."
Yes when you keep me out of your posts. You reall need to get over me.

<< Previous

Bullboard Posts

Next >>

Thesis Gold makes high-grade discovery at Ring Zone